Following the disruption of COVID-19, your biopharma company may be scaling up production of new life-saving treatments, researching new modalities or focusing on laboratory productivity and efficiency. There’s been record growth in life sciences research and development (R&D) spending and it’s expected to reach $213 billion by 2024. With billions of dollars of investment on the line, extracting the most value from your laboratory and manufacturing facilities will be essential in achieving your goals. It’s especially important to anticipate and address critical challenges in your technical operations and reduce risk. Whether you lease or own your facilities, here are five ways to increase efficiency and set the stage for innovation.